{
  "id": "adv_mhgap#screening_cues_4d7d8a1b",
  "content": "utilization, higher mortality rates and increased psychological interventions were carried out\ncaregiver burden. in LMICs.\ny Psychological interventions may not be feasible as\nImplementation considerations\na treatment for people with severe dementia and\ny Psychological therapies may be preferred to\nsymptoms of depression due to impaired cognitive\nantidepressant medicine, which has been shown\nfunction. An assessment by a suitably qualified\nto lack efficacy. High levels of treatment adherence\nhealth worker is the most appropriate means of\nwere reported in most of the trials included in the\njudging the most appropriate treatment choice.\n2014 Cochrane Review.\ny For treatment of severe depression in people living\ny Presented evidence in the 2014 Cochrane Review is\nwith dementia, also refer to the existing mhGAP\nbased on trials that included people living with mild-\nrecommendation, which was validated by the\nto-moderate dementia (106). The ability of people\nGDG for this update. It reads as follows: “In people\nliving with more severe dementia to access and\nwith dementia and severe depression, or when\nparticipate in these therapies depends not only on\npsychosocial interventions prove ineffective, the\ntheir mental capacity but also other comorbidities\nuse of selective serotonin reuptake inhibitors (SSRIs)",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "work",
      "screening_cues",
      "referral",
      "management"
    ],
    "is_clinical": true,
    "is_advice": true
  },
  "index_text": "General — Screening Cues utilization, higher mortality rates and increased psychological interventions were carried out\ncaregiver burden. in LMICs.\ny Psychological interventions may not be feasible as\nImplementation considerations\na treatment for people with severe dementia and\ny Psychological therapies may be preferred to\nsymptoms of depression due to impaired cognitive\nantidepressant medicine, which has been shown\nfunction. An assessment by a suitably qualified\nto lack efficacy. High levels of treatment adherence\nhealth worker is the most appropriate means of\nwere reported in most of the trials included in the\njudging the most appropriate treatment choice.\n2014 Cochrane Review.\ny For treatment of severe depression in people living\ny Presented evidence in the 2014 Cochrane Review is\nwith dementia, also refer to the existing mhGAP\nbased on trials that included people living with mild-\nrecommendation, which was validated by the\nto-moderate dementia (106). The ability of people\nGDG for this update. It reads as follows: “In people\nliving with more severe dementia to access and\nwith dementia and severe depression, or when\nparticipate in these therapies depends not only on\npsychosocial interventions prove ineffective, the\ntheir mental capacity but also other comorbidities\nuse of selective serotonin reuptake inhibitors (SSRIs) Utilization, higher mortality rates and increased psychological interventions were carried out\ncaregiver burden. in lmics."
}